Coronavirus: Alarm at German AstraZeneca pause as circumstances spike

Emer Cooke, government director of the European Medicines Company, stated the EMA was nonetheless “firmly satisfied” of the advantages of the AstraZeneca drug, and she or he identified that blood clots highlighted by some nations had been comparatively widespread within the common inhabitants. The principle query was whether or not it was an actual side-effect of the vaccine or a coincidence, she stated.

Source link

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *